ZVRA FY 2024 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M-14.0% YoY

Gross Profit

$16M68.6% margin

Operating Income

-$87M-368.5% margin

Net Income

-$106M-446.9% margin

EPS (Diluted)

$-2.28

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$70M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$178M

Total Liabilities

$138M

Stockholders' Equity

$40M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$27M	-14.0%
Gross Profit	$16M	$25M	-33.9%
Operating Income	-$87M	-$50M	-75.4%
Net Income	-$106M	-$46M	-129.1%